2024
Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis
Moledina D, Obeid W, Smith R, Rosales I, Sise M, Moeckel G, Kashgarian M, Kuperman M, Campbell K, Lefferts S, Meliambro K, Bitzer M, Perazella M, Luciano R, Pober J, Cantley L, Colvin R, Wilson F, Parikh C. Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. Journal Of Clinical Investigation 2024, 134: e180583. PMID: 38488004, PMCID: PMC10940080, DOI: 10.1172/jci180583.Peer-Reviewed Original ResearchConceptsDiagnosis of acute interstitial nephritisAcute interstitial nephritisUrinary CXCL9Interstitial nephritis
2022
Urine Proteomic Analysis Identifies Interferon Gamma Downstream Chemokine CXCL-9 as a Biomarker for Diagnosis of Acute Interstitial Nephritis
Moledina D, Obeid W, Sise M, Rosales I, Smith R, Colvin R, Kuperman M, Kashgarian M, Moeckel G, Wilson F, Parikh C. Urine Proteomic Analysis Identifies Interferon Gamma Downstream Chemokine CXCL-9 as a Biomarker for Diagnosis of Acute Interstitial Nephritis. Journal Of The American Society Of Nephrology 2022, 33: 71-72. DOI: 10.1681/asn.20223311s171c.Peer-Reviewed Original ResearchDiagnosis of acute interstitial nephritisChemokines CXCL-9Acute interstitial nephritisCXCL-9Interstitial nephritis